Skip to main content
OpenTrials

Clinical trial condition

Dermatitis, Atopic

Explore clinical trials studying Dermatitis, Atopic. Study availability and eligibility vary by location and protocol.

1,192 public trials 151 recruiting studies
Refine in advanced search Browse all conditions

Dermatitis, Atopic trial results

Active, Not Recruiting

A Study of Lebrikizumab (LY3650150) With/Without Topical Corticosteroid Treatment in Participants With Moderate-to-Severe Atopic Dermatitis

NCT06280716

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Wannan Medical College Yijishan Hospital Wuhu, Anhui, China
  • China-Japan Friendship Hospital Beijing, Beijing Municipality, China
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • Beijing Children's hospital, Capital Medical University Beijing, Beijing Municipality, China
View all 46 locations
View Trial Details
Active, Not Recruiting

Dupilumab Step-down Strategy to Maintain Remission in Adult and Adolescents Patients With Atopic Dermatitis

NCT05642208

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Amiens University hospital Amiens, France
  • CHU d'Angers Angers, France
  • Hôpital Victor Dupouy Argenteuil, France
  • CHU de Besançon Besançon, France
View all 32 locations
View Trial Details
Active, Not Recruiting

Observational Evaluation of Atopic Dermatitis in Pediatric Patients

NCT03687359

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +9 more
Locations
  • C Squared Research Center- Site Number : 8400068 Birmingham, Alabama, United States
  • Cahaba Dermatology & Skin Health Center- Site Number : 8400046 Birmingham, Alabama, United States
  • C2 Research Center, LLC- Site Number : 8400071 Montgomery, Alabama, United States
  • Phoenix Children's Hospital, Inc.- Site Number : 8400015 Phoenix, Arizona, United States
View all 182 locations
View Trial Details
Active, Not Recruiting

A Study to Assess Real-World Use, Safety, and Effectiveness of Oral Upadacitinib in Adult and Adolescent (>=12 Years Old) Participants With Atopic Dermatitis

NCT05081557

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Hospital Universitario Austral /ID# 241607 Pilar, Buenos Aires, Argentina
  • Buenos Aires Skin /ID# 241606 Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina
  • CEDIC Centro de Investigaciones Clinicas /ID# 241605 Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina
  • Instituto de Neumonologia y Dermatologia /ID# 241604 Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina
View all 140 locations
View Trial Details
Active, Not Recruiting

Evaluation of 611 in Combination With Topical Corticosteroid in Participants With Moderate to Severe Atopic Dermatitis

NCT06554847

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
Locations
  • Shanghai Dermatology Hospital Shanghai, Shanghai Municipality, China
  • Hangzhou First People's Hospital Hangzhou, Zhejiang, China
  • The First Affiliated Hospital of Ningbo University Ningbo, Zhejiang, China
View Trial Details
Active, Not Recruiting

A Long-term Data Collection Study of Participants in France Aged 6 Years Old or More With Atopic Dermatitis Receiving Dupilumab

NCT06169527

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Investigational Site Number: 2500041 Amiens, France
  • Investigational Site Number: 2500037 Angers, France
  • Investigational Site Number: 2500021 Argenteuil, France
  • Investigational Site Number: 2500044 Armentières, France
View all 42 locations
View Trial Details

Related conditions